These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3065582)

  • 1. Trials of thymus extract TFX administration in dermatological patients resistant to conventional treatment methods.
    Turowski G; Sanokowska E; Dynowska D
    Mater Med Pol; 1988; 20(2):128-31. PubMed ID: 3065582
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prospects of using immunocorrective treatment with an active thymus factor (taktivin) in dermatology].
    Skripkin IuK; Korotkiĭ NG; Udzhukhu VIu; Arion VIa; Eletskiĭ AIu
    Vestn Dermatol Venerol; 1986; (4):4-7. PubMed ID: 3487189
    [No Abstract]   [Full Text] [Related]  

  • 3. [Calf thymus extract (TFX-Polfa) in the treatment of pollinosis. Clinical trials by the double-blind method using a placebo].
    Kowalski ML; Kuna P; Grzegorczyk J; Rozniecki J
    Pol Tyg Lek; 1987 Jun; 42(24):739-42. PubMed ID: 3313315
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical effectiveness of T-activin in the treatment of cutaneous forms of lupus erythematosus].
    Skripkin IuK; Biriukov AV; Stenina MA; Skripnik AIu; Korotkiĭ NG
    Vestn Dermatol Venerol; 1985 May; (5):8-11. PubMed ID: 3898631
    [No Abstract]   [Full Text] [Related]  

  • 5. [Results of the treatment of chronic active hepatitis with thymus extract (TFX-Polfa). (Evaluation of the preliminary stage of clinical studies)].
    Kiczka W; Juszczyk J; Adamek J
    Pol Tyg Lek; 1987 Feb; 42(7):192-6. PubMed ID: 3299322
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapeutic effectiveness of the immuno stimulating extract of the calf thymus (TFX-Polfa) in cases of acute dermatomyositis].
    Stasiak A; Dudkiéwicz H; Dabrowski M; Dabrowska B; Wasowska B; Brzosko W
    Pol Tyg Lek; 1983 Mar; 38(13):389-92. PubMed ID: 6605525
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical trial of treatment with the preparation TFX "Polfa" of 4 patients with acquired immunologic deficiency syndromes].
    Romański B; Montowska L; Zbikowska-Götz M; Staszyńska M
    Pol Tyg Lek; 1985 Oct 7-14; 40(40-41):1139-42. PubMed ID: 3911181
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immunotherapy of chronic active hepatitis (HBsAg+) with calf thymus extract (TFX-Polfa). Clinical evaluation].
    Cianciara J; Babiuch L; Górska E; Kassur B
    Pol Tyg Lek; 1984 Aug; 39(33):1097-101. PubMed ID: 6390376
    [No Abstract]   [Full Text] [Related]  

  • 9. Initial observations on the administration of thymus extract (TFX) in patients with alimentary tract neoplasms.
    Cybulski L; Turowski G; Politowski M; Urban A; Turaszwili T; Zubel M
    Pol Med Sci Hist Bull (1973); 1976; 15(1):47-9. PubMed ID: 995755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The results of treating patients with endogenous bronchial asthma with TFX].
    Moniuszko T; Szymański W; Chyrek-Borowska S
    Pol Tyg Lek; 1988 Jan 18-25; 43(3-4):111-3. PubMed ID: 3387316
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hepatological news (2). The twilight of immunosuppression in hepatitis B--the dawn of new methods?].
    Juszczyk J
    Pol Tyg Lek; 1982 Nov; 37(43):1295-300. PubMed ID: 6761672
    [No Abstract]   [Full Text] [Related]  

  • 12. First trials of immunopotentiation by thymus extract (TFX) in surgical patients with malignant disease.
    Turowski G; Cybulski L; Politowski M; Turaszwili T; Zubel M
    Acta Med Pol; 1976; 17(1):19-39. PubMed ID: 1258690
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical aspects and course of extrapulmonary sarcoidosis].
    Ozerova LV; Romanov VV; Dobychina AI; Bugrova KM; Starilova IP; Anan'eva NK
    Probl Tuberk; 1995; (2):9-11. PubMed ID: 7777470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Taktivin treatment of immunologic disorders in patients with nonspecific ulcerative colitis].
    Shafer NP
    Klin Med (Mosk); 1993; 71(3):45-7. PubMed ID: 8015217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunological criteria for using thymus preparations and tuberculin therapy in the combined treatment of patients with tuberculosis].
    Knoring BE; Vasil'ev AV; Sakharova IIa; Machkova NA; Ivanova LA
    Probl Tuberk; 1988; (3):27-31. PubMed ID: 3260381
    [No Abstract]   [Full Text] [Related]  

  • 16. [Immunologic and patho-clinical observations of rectal cancer in a patient with a history of long-term administration of thymus extract (TFX)].
    Turowski G; Urban A; Cybulski L; Turaszwili T; Zubel M
    Patol Pol; 1975; 26(2):163-74. PubMed ID: 1153229
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical trial of immunoregulation using the TFX Polfa preparation in non-Hodgkin's lymphoma].
    Górski J; Kicińska M; Gawrecka G
    Przegl Lek; 1988; 45(7):555-8. PubMed ID: 3070639
    [No Abstract]   [Full Text] [Related]  

  • 18. [An attempt of immunological stimulation of patients with proliferative and applastic diseases of the haematopoietic system by means of calf's thymus extract (TFX) (author's transl)].
    Aleksandrowicz J; Szmigiel Z; Czarnecki J; Turowski G; Skotnicki AB
    Przegl Lek; 1975; 32(2):277-9. PubMed ID: 1167699
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immunotherapy of breast cancer patients].
    Korolev VI; Bendiug GD; Dziubko NiA ; Ponomarev IN; Krivorotov AA
    Vrach Delo; 1987 Jun; (6):90-3. PubMed ID: 3630094
    [No Abstract]   [Full Text] [Related]  

  • 20. Thymostimulin prophylaxis of postoperative infections in anergic patients.
    Farina EC; Garino M; Balbo G
    Can J Surg; 1986 Nov; 29(6):445-6. PubMed ID: 3536050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.